OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea flag South Korea · Delayed Price · Currency is KRW
43,000
+1,350 (3.24%)
Apr 4, 2025, 3:30 PM KST

OliX Pharmaceuticals Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
801,005355,531233,568278,859561,830681,166
Upgrade
Market Cap Growth
52.22%52.22%-16.24%-50.37%-17.52%146.02%
Upgrade
Enterprise Value
828,406392,701247,386238,494524,125657,538
Upgrade
Last Close Price
43000.0019260.0014580.0020350.0041000.0050300.00
Upgrade
PS Ratio
127.5762.6313.6929.92152.91275.30
Upgrade
PB Ratio
44.4719.254.644.2128.9515.02
Upgrade
P/TBV Ratio
22.0222.024.924.4834.2915.93
Upgrade
EV/Sales Ratio
145.9269.1714.5025.59142.64265.75
Upgrade
Debt / Equity Ratio
2.122.120.780.671.920.32
Upgrade
Asset Turnover
0.070.070.140.090.040.04
Upgrade
Inventory Turnover
0.490.490.280.400.510.18
Upgrade
Quick Ratio
0.440.444.711.591.2415.21
Upgrade
Current Ratio
0.520.524.901.651.2915.38
Upgrade
Return on Equity (ROE)
-118.18%-118.18%-32.78%-65.68%-90.11%-44.48%
Upgrade
Return on Assets (ROA)
-22.20%-22.20%-9.65%-12.75%-18.33%-16.40%
Upgrade
Return on Capital (ROIC)
-26.23%-26.23%-11.37%-16.76%-25.98%-19.92%
Upgrade
Earnings Yield
-5.08%-11.44%-8.18%-6.99%-5.29%-2.85%
Upgrade
FCF Yield
-5.18%-11.68%-12.84%-11.80%-3.62%-0.67%
Upgrade
Buyback Yield / Dilution
-16.74%-16.74%-5.28%-0.13%-4.06%-1.00%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.